机构

• 上海药物研究所 [6]
• 南海海洋研究所 [1]
• 大连化学物理研究所 [1]

采集方式

• OAI收割 [8]

内容类型

• 期刊论文 [7]
• 会议论文 [1]

发表日期

• 2022 [1]
• 2020 [1]
• 2018 [1]
• 2015 [2]
• 2014 [1]
• 2012 [1]
• 更多

学科主题

• 物理化学 [1]

筛选

浏览/检索结果: 共8条，第1-8条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2 期刊论文  OAI收割 ANTIVIRAL RESEARCH, 2022, 卷号: 208, 页码: 10 作者:  Shang, Weijuan;  Dai, Wenhao;  Yao, Cheng;  Xu, Ling;  Tao, Xiangming   |  收藏  |  浏览/下载：15/0  |  提交时间：2023/04/10 SARS-CoV-2  SARS-CoV-2 variants  FB2001  Main protease  PBPK  Anti-SARS-CoV-2 in vivo   Physiologically Based Pharmacokinetic Model for the Biotransportation of Arsenic in Marine Medaka (Oryzias melastigma) 期刊论文  OAI收割 ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2020, 卷号: 54, 期号: 12, 页码: 7485, 7493 作者:  Zhang, Wei;  Song, Dongdong;  Tan, Qiao-Guo;  Wang, Wen-Xiong;  Zhang, Li   |  收藏  |  浏览/下载：14/0  |  提交时间：2020/09/22 Glycyrrhizin has a high likelihood to be a victim of drug-drug interactions mediated by hepatic organic anion-transporting polypeptide 1B1/1B3 期刊论文  OAI收割 BRITISH JOURNAL OF PHARMACOLOGY, 2018, 卷号: 175, 期号: 17, 页码: 3486-3503 作者:  Dong, Jiajia;  Olaleye, Olajide E.;  Jiang, Rongrong;  Li, Jing;  Lu, Chuang   |  收藏  |  浏览/下载：96/0  |  提交时间：2019/01/08 Preclinical pharmacokinetics of TPN729MA, a novel PDE5 inhibitor, and prediction of its human pharmacokinetics using a PBPK model 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2015, 卷号: 36, 期号: 12, 页码: 1528-1536 作者:  Gao, Zhi-wei;  Zhu, Yun-ting;  Yu, Ming-ming;  Zan, Bin;  Liu, Jia   |  收藏  |  浏览/下载：30/0  |  提交时间：2019/01/08 TPN729MA  PDE5 inhibitor  erectile dysfunction  pharmacokinetics  human PK prediction  physiologically based pharmacokinetic model   preclinicalpharmacokineticsoftpn729maanovelpde5inhibitorandpredictionofitshumanpharmacokineticsusingapbpkmodel 期刊论文  OAI收割 actapharmacologicasinica, 2015, 卷号: 36, 期号: 12, 页码: 1528 作者:     |  收藏  |  浏览/下载：13/0  |  提交时间：2020/07/01 HUMAN DRUG CLEARANCE  PHOSPHODIESTERASE-5 INHIBITORS  CLINICAL PHARMACOKINETICS  ERECTILE DYSFUNCTION  TISSUE DISTRIBUTION  ORAL PHARMACOKINETICS  RECEPTOR ANTAGONIST  DIVERSE COMPOUNDS  IN-VIVO  ABSORPTION  TPN729MA  PDE5 inhibitor  erectile dysfunction  pharmacokinetics  human PK prediction  physiologically based pharmacokinetic model   Predicting pharmacokinetics of anti-cancer drug, famitinib in human using physiologically based pharmacokinetic model 期刊论文  OAI收割 Acta Pharmaceutica Sinica, 2014, 卷号: 49, 期号: 12, 页码: 1684-1688 作者:  Yu Mingming;  Gao Zhiwei;  Chen Xiaoyan;  Zhong Dafang   |  收藏  |  浏览/下载：34/0  |  提交时间：2019/01/08 famitinib  physiologically based pharmacokinetic model  species extrapolation  tyrosine kinase inhibitor   Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2012, 卷号: 33, 期号: 11, 页码: 1359 作者:  Li Guofu;  Wang Kun;  Chen Rui;  Zhao Haoru;  Yang Jin   |  收藏  |  浏览/下载：10/0  |  提交时间：2020/12/24 TISSUE DISTRIBUTION  DRUG DISCOVERY  INTRASUBJECT VARIABILITY  PBPK SIMULATION  P-GP  ABSORPTION  POPULATION  PREDICTION  BIOAVAILABILITY  IDENTIFICATION  bisoprolol  whole-body physiologically based pharmacokinetic model  drug absorption  drug distribution  renal function impairment   Hepatobiliary disposition of deoxyschizandrin in perfused rat livers in situ 会议论文  OAI收割 16th north american regional issx meeting, 美国, 2009-10-18 吴敬敬; 张延延; 葛广波; 杨凌 收藏  |  浏览/下载：12/0  |  提交时间：2011/07/11